PE20180576A1 - ANTICUERPOS MONOCLONALES ESPECIFICOS PARA EL ANTIGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, UTILES PARA LA DETECCION Y EL DIAGNOSTICO DE LA INFECCION CAUSADA POR VRSh - Google Patents
ANTICUERPOS MONOCLONALES ESPECIFICOS PARA EL ANTIGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, UTILES PARA LA DETECCION Y EL DIAGNOSTICO DE LA INFECCION CAUSADA POR VRShInfo
- Publication number
- PE20180576A1 PE20180576A1 PE2018000144A PE2018000144A PE20180576A1 PE 20180576 A1 PE20180576 A1 PE 20180576A1 PE 2018000144 A PE2018000144 A PE 2018000144A PE 2018000144 A PE2018000144 A PE 2018000144A PE 20180576 A1 PE20180576 A1 PE 20180576A1
- Authority
- PE
- Peru
- Prior art keywords
- vrsh
- human
- hybridomas
- secreted
- antigen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C07K16/11—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
Abstract
SE REFIERE A UN ANTICUERPO MONOCLONAL O UN FRAGMENTO DEL MISMO QUE SE UNE A LA PROTEINA P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh) QUE COMPRENDE: A) UNA REGION VARIABLE DE LA CADENA PESADA QUE TIENE UNA SECUENCIA CON AL MENOS UN 99% DE IDENTIDAD CON LA SEQ ID N°:1 O 5, O B) UNA REGION VARIABLE DE LA CADENA LIVIANA QUE TIENE UNA SECUENCIA CON AL MENOS UN 99% DE IDENTIDAD CON LA SEQ ID N°:2 O 6. TAMBIEN SE REFIERE A UN CONJUNTO DE SECUENCIAS NUCLEOTIDICAS QUE CODIFICAN DICHO ANTICUERPO, Y A UN METODO IN VITRO O EX VIVO DE DIAGNOSTICO DE INFECCION POR VRSh EN UNA MUESTRA BIOLOGICA TAL COMO SECRECIONES NASALES, BRONQUIALES, ENTRE OTROS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2015002152A CL2015002152A1 (es) | 2015-07-31 | 2015-07-31 | Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20180576A1 true PE20180576A1 (es) | 2018-04-04 |
Family
ID=56610056
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2018000144A PE20180576A1 (es) | 2015-07-31 | 2016-07-25 | ANTICUERPOS MONOCLONALES ESPECIFICOS PARA EL ANTIGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, UTILES PARA LA DETECCION Y EL DIAGNOSTICO DE LA INFECCION CAUSADA POR VRSh |
| PE2021001936A PE20220004A1 (es) | 2015-07-31 | 2016-07-25 | Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2021001936A PE20220004A1 (es) | 2015-07-31 | 2016-07-25 | Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10858419B2 (es) |
| EP (2) | EP3328884B1 (es) |
| KR (1) | KR102679351B1 (es) |
| CN (1) | CN108474017B (es) |
| AR (1) | AR105541A1 (es) |
| CA (1) | CA2994219C (es) |
| CL (1) | CL2015002152A1 (es) |
| CO (1) | CO2018001010A2 (es) |
| ES (2) | ES2784888T3 (es) |
| MX (2) | MX2018001244A (es) |
| PE (2) | PE20180576A1 (es) |
| PT (2) | PT3517546T (es) |
| RU (1) | RU2716990C2 (es) |
| UY (1) | UY36820A (es) |
| WO (1) | WO2017021815A2 (es) |
| ZA (1) | ZA201800938B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102017127857B4 (de) | 2017-11-24 | 2023-10-12 | Lipozyt Marker UG (haftungsbeschränkt) | Verwendung des ADIPOQ Genexpressionslevels zur Einordnung eines Probanden in Risikogruppen bei der Prognose oder Diagnose einer Diabetes mellitus Typ II Erkrankung |
| EP3848389A4 (en) * | 2018-09-03 | 2022-04-13 | Pontificia Universidad Católica De Chile | SPECIFIC MONOCLONAL ANTIBODIES AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS (HRSV) N-ANTIGEN FOR TREATMENT, DETECTION AND DIAGNOSIS OF INFECTION |
| CL2018003869A1 (es) | 2018-12-28 | 2021-01-15 | Univ Pontificia Catolica Chile | Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv |
| EP3825591B1 (en) | 2019-11-22 | 2025-08-06 | Hamilton Sundstrand Corporation | Hydraulic damping valve |
| CN113354734B (zh) * | 2021-07-14 | 2021-12-14 | 北京祥瑞生物制品有限公司 | 一种快速检测病毒的试剂盒及其制备方法 |
| CN115925909B (zh) * | 2022-09-27 | 2023-07-21 | 深圳重链生物科技有限公司 | 抗呼吸道合胞病毒抗体及其相关应用 |
| CN115838419B (zh) * | 2022-09-27 | 2023-06-30 | 深圳重链生物科技有限公司 | 抗呼吸道合胞病毒抗体及其相关应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824307A (en) | 1991-12-23 | 1998-10-20 | Medimmune, Inc. | Human-murine chimeric antibodies against respiratory syncytial virus |
| US7223410B1 (en) * | 1994-08-05 | 2007-05-29 | Sanofi Pasteur Limited | Inactivated respiratory syncytial viral vaccines |
| US6258529B1 (en) | 1994-12-01 | 2001-07-10 | Oravax, Inc. | PCR amplification of rearranged genomic variable regions of immunoglobulin genes |
| US7527787B2 (en) * | 2005-10-19 | 2009-05-05 | Ibc Pharmaceuticals, Inc. | Multivalent immunoglobulin-based bioactive assemblies |
| US20040096451A1 (en) | 2002-07-25 | 2004-05-20 | Young James F. | Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies |
| MXPA04008088A (es) * | 2002-02-21 | 2005-09-30 | Medimmune Vaccines Inc | Sistema de expresion del virus de parainfluenza recombinante y vacunas que comprenden antigenos heterologos derivados del metapneumovirus. |
| AU2003295339B2 (en) * | 2002-09-27 | 2009-03-26 | Medimmune, Llc | Functional mutations in respiratory syncytial virus |
| JP2009504686A (ja) * | 2005-08-15 | 2009-02-05 | アラーナ・テラピューティクス・リミテッド | 新世界霊長類領域を用いるキメラ抗体 |
| RU2521669C2 (ru) * | 2008-10-31 | 2014-07-10 | Торэй Индастриз, Инк. | Способ иммунологического анализа белка cxcl1 человека |
| CL2011003002A1 (es) | 2011-11-25 | 2012-05-25 | Univ Pontificia Catolica Chile | Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento. |
-
2015
- 2015-07-31 CL CL2015002152A patent/CL2015002152A1/es unknown
-
2016
- 2016-07-25 ES ES16832387T patent/ES2784888T3/es active Active
- 2016-07-25 MX MX2018001244A patent/MX2018001244A/es unknown
- 2016-07-25 CA CA2994219A patent/CA2994219C/en active Active
- 2016-07-25 US US15/748,979 patent/US10858419B2/en active Active
- 2016-07-25 KR KR1020187005939A patent/KR102679351B1/ko active Active
- 2016-07-25 CN CN201680052944.0A patent/CN108474017B/zh active Active
- 2016-07-25 PE PE2018000144A patent/PE20180576A1/es unknown
- 2016-07-25 EP EP16832387.1A patent/EP3328884B1/en active Active
- 2016-07-25 ES ES18203701T patent/ES2786637T3/es active Active
- 2016-07-25 WO PCT/IB2016/054424 patent/WO2017021815A2/en not_active Ceased
- 2016-07-25 PE PE2021001936A patent/PE20220004A1/es unknown
- 2016-07-25 RU RU2018103933A patent/RU2716990C2/ru active
- 2016-07-25 EP EP18203701.0A patent/EP3517546B1/en active Active
- 2016-07-25 PT PT182037010T patent/PT3517546T/pt unknown
- 2016-07-25 PT PT168323871T patent/PT3328884T/pt unknown
- 2016-07-27 UY UY0001036820A patent/UY36820A/es not_active Application Discontinuation
- 2016-07-29 AR ARP160102326A patent/AR105541A1/es unknown
-
2018
- 2018-01-29 MX MX2022010471A patent/MX2022010471A/es unknown
- 2018-01-30 CO CONC2018/0001010A patent/CO2018001010A2/es unknown
- 2018-02-12 ZA ZA2018/00938A patent/ZA201800938B/en unknown
-
2020
- 2020-11-02 US US17/087,103 patent/US11873331B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3328884A2 (en) | 2018-06-06 |
| PT3517546T (pt) | 2020-05-22 |
| PE20220004A1 (es) | 2022-01-05 |
| US20180327483A1 (en) | 2018-11-15 |
| CN108474017B (zh) | 2021-08-27 |
| ES2784888T3 (es) | 2020-10-01 |
| AR105541A1 (es) | 2017-10-11 |
| WO2017021815A2 (en) | 2017-02-09 |
| ZA201800938B (en) | 2019-07-31 |
| CA2994219C (en) | 2024-02-20 |
| EP3517546A1 (en) | 2019-07-31 |
| RU2018103933A3 (es) | 2019-08-28 |
| US10858419B2 (en) | 2020-12-08 |
| EP3328884B1 (en) | 2020-01-01 |
| CN108474017A (zh) | 2018-08-31 |
| PT3328884T (pt) | 2020-04-08 |
| RU2716990C2 (ru) | 2020-03-17 |
| WO2017021815A3 (en) | 2017-05-11 |
| CA2994219A1 (en) | 2017-02-09 |
| MX2018001244A (es) | 2018-04-24 |
| US20210070844A1 (en) | 2021-03-11 |
| US11873331B2 (en) | 2024-01-16 |
| ES2786637T3 (es) | 2020-10-13 |
| MX2022010471A (es) | 2022-09-19 |
| BR112018002031A2 (pt) | 2018-09-11 |
| EP3517546B1 (en) | 2020-02-26 |
| KR102679351B1 (ko) | 2024-06-27 |
| CL2015002152A1 (es) | 2016-06-03 |
| CO2018001010A2 (es) | 2018-04-30 |
| UY36820A (es) | 2017-01-31 |
| EP3328884A4 (en) | 2018-06-06 |
| RU2018103933A (ru) | 2019-08-28 |
| KR20180030919A (ko) | 2018-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20180576A1 (es) | ANTICUERPOS MONOCLONALES ESPECIFICOS PARA EL ANTIGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, UTILES PARA LA DETECCION Y EL DIAGNOSTICO DE LA INFECCION CAUSADA POR VRSh | |
| MX374810B (es) | Anticuerpos 4-1bb anti-humano y usos de los mismos | |
| AR090973A1 (es) | Anticuerpos utiles para el diagnostico del cancer | |
| CL2019000067A1 (es) | Anticuerpos nuevos que se unen específicamente a los epítopos del virus del zika y usos de los mismos. | |
| PE20220708A1 (es) | Anticuerpos anti-cd73 | |
| MX2021007006A (es) | Anticuerpo anti-calicreina-2 humanizado. | |
| PE20142041A1 (es) | Anticuerpos anti-il-36r | |
| CO6700829A2 (es) | Moduladores novedosos y métodos de uso | |
| AR095432A1 (es) | Proteínas de unión a antígeno | |
| PE20140673A1 (es) | Nuevos moduladores y metodos para su uso | |
| PE20181054A1 (es) | Anticuerpos anti-cd19 humano humanizados y metodos de utilizacion | |
| MX2009009226A (es) | Anticuerpos recombinantes para el tratamiento de infecciones con el virus respiratorio sincitial. | |
| MX2016010791A (es) | Inmunoterapia con multiples objetivos dirigida por biomarcadores. | |
| AR104264A1 (es) | Neutralización del virus de chikungunya mediada por anticuerpos | |
| MX383206B (es) | Preparación de anticuerpos de cultivos de célula de ovario de hámster chino para conjugación. | |
| PE20181498A1 (es) | Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv | |
| PE20141683A1 (es) | Anticuerpos monoclonales especificos para el antigeno m2-1 del virus respiratorio sincicial (vrs) | |
| CO2021008770A2 (es) | Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv | |
| CO2021008774A2 (es) | Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu | |
| PE20171734A1 (es) | Anticuerpos monoclonales especificos del antigeno m del virus metapneumovirus humano (hmpv) y su uso en un metodo de diagnostico | |
| AR087654A1 (es) | METODO DIAGNOSTICO DE ANIMALES VACUNADOS CON PESTIVIRUS QUIMERICO EN EL CUAL LA PROTEINA Eʳⁿˢ DEL VIRUS DE LA DIARREA VIRAL BOVINA (BVDV) ES REMPLAZADA POR PROTEINA Eʳⁿˢ DE PESTIVIRUS DE ANTILOPE AMERICANO | |
| MX2022003719A (es) | Anticuerpos anti-il-27 y sus usos. | |
| MX393714B (es) | Anticuerpo para sesgar proporciones de sexos y metodos de uso del mismo. | |
| MX2018004071A (es) | Polipeptidos como anticuerpos y usos de los mismos. | |
| CL2017001471A1 (es) | Nueva estructura de proteína producida por un anticuerpo efectivo usado para inmunización |